Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CyBio and MACHEREY-NAGEL Collaborate to Develop Applications for Automated DNA/RNA Preparation

Published: Tuesday, July 31, 2007
Last Updated: Monday, August 06, 2007
Bookmark and Share
The cooperation focuses on the automation of nucleic acid preparation from various biological sample materials and the purification of PCR products.

CyBio AG and MACHEREY-NAGEL GmH Co. KG have signed a non-exclusive collaboration for the joint development of applications to automate MACHEREY-NAGEL kits on CyBio liquid handling instruments.

The cooperation focuses on the automation of nucleic acid preparation from various biological sample materials and the purification of PCR products, e.g. for subsequent sequencing and cloning experiments. Due to continuous advancement of the brands NucleoSpin®, NucleoMag und NucleoFast, MACHEREY-NAGEL has gained a worldwide leading position in this field.

For CyBio the cooperation is a further milestone to strategically strengthen the company’s position in genomics. The CyBi®-GeneRobots product family has been designed for genomics applications and offers specific solutions for varying automation levels.

CyBi®-GeneRobots incorporate the well-known pipettors CyBi®-DiluSpro, CyBi®-Well vario, CyBi®-Genomics Workstation and CyBi®-RoboSpense.

The cooperation of both partners will enable the automation of MACHEREY-NAGEL’s DNA/RNA preparation kits with CyBio’s liquid handling instruments, addressing a broad range of customers with diverse demands regarding application, automation and throughput.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Spain’s Pharmaceutical Companies Trust in the Reliability of CyBio’s Liquid Handling
CyBio’s Spanish distribution partner Inycom will present CyBio’s products at the Farmameeting 2006 in Madrid.
Saturday, January 14, 2006
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!